# A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).

> clinical trial · VERIFIED · 2026-08-03

Status: RECRUITING · Sponsor: Shanghai Zhongshan Hospital · Condition: Multiple Myeloma

- Company: Shanghai Zhongshan Hospital
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07638683

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.